Gov. Rick Snyder (R) signed into law HB 4472 pertaining to the substitution of interchangeable biosimilars with various options for pharmacists to communicate the product dispensed to the prescriber effective Tuesday, May 29.
For more information, contact NACDS’ Joel Kurzman at 847-905-0555.